Naobios, Tokyo Metropolitan Institute Partner On Live-Attenuated
23 Oct 2025 //
BUSINESSWIRE
Naobios, Nuvonis, EVI Partner on Mfg of Influenza Challenge Agent
02 Sep 2025 //
BUSINESSWIRE
Naobios & Sumagen Optimize HIV Vaccine Candidate For Production
29 Oct 2024 //
BUSINESSWIRE
Naobios manufactures FluGen’s M2SR influenza vaccine
21 Sep 2021 //
PHARMBIWEB

Market Place
Sourcing Support